Clinical Trials Browser

Withdrawn × Gastrointestinal Stromal Tumors × Imatinib Mesylate × Clear all

NCT02268435 2015-08-04

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Phase 1 Withdrawn

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors